Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:52:26 EDT Sun 21 Jun 2026
Enter Symbol
or Name
USA
CA



Q:NEO - NEOGENOMICS INC - https://www.neogenomics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NEO - Q0.410.70·11.540.211.13+0.757.26,707.610.58  11.21  10.5813.74  4.72Jun 18Jun 1715 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-06-17 06:00U:NEONews ReleaseNeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
2026-06-15 17:24U:NEONews ReleaseNeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
2026-05-26 07:05U:NEONews ReleaseNeoGenomics to Present New Research at ASCO Annual Meeting 2026
2026-05-15 09:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming Investor Conferences
2026-04-28 16:05U:NEONews ReleaseNeoGenomics Reports First Quarter 2026 Results
2026-04-23 07:05U:NEONews ReleaseNeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
2026-04-13 07:05U:NEONews ReleaseNeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
2026-04-07 07:05U:NEONews ReleaseNeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
2026-03-16 07:05U:NEONews ReleaseNeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
2026-02-25 07:05U:NEONews ReleaseNeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
2026-02-18 07:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming Investor Conferences
2026-02-17 07:05U:NEONews ReleaseNeoGenomics Reports Fourth Quarter and Full Year 2025 Results
2026-02-12 07:05U:NEONews ReleaseNeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
2026-01-27 07:05U:NEONews ReleaseNeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
2026-01-12 07:05U:NEONews ReleaseNeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
2026-01-05 07:05U:NEONews ReleaseNeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
2025-12-30 07:05U:NEONews ReleaseNeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its Board of Directors
2025-12-15 07:05U:NEONews ReleaseNeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
2025-12-10 07:05U:NEONews ReleaseNeoGenomics to Present New ctDNA Research at SABCS 2025
2025-12-08 08:05U:NEONews ReleaseNeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025